Downing Ventures
VC Fund
London, United Kingdom
Downing Ventures is a division of Downing LLP. They invest venture capital into early and growth stage technology businesses. Our belief is that technology now forms an integral part of the everyday lives of consumers, corporations and governments. Further, they believe that they are now experiencing the benefits of the second wave of technologydevelopment, which is now based on sound infrastructure. Investing into this trend, they look for: Visionary entrepreneurs, with the ability to execute as well as dream. Large (potential) addressable markets. Distinct product / service advantages. Limited adoption risk for customers. They seek to invest 250,000 to 5 million per company. They will invest in seed-stage deals and Series A deals, and then look to continue to support those companies through phases of subsequent growth. Fundamentally, they back entrepreneurs. They are supportive, hopefully helpful, investors.
- Total investments:
- 131
- Last investment:
- Lead investor:
- 31%
- Fund size:
- $2.8M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Downing Ventures invests in
Stages Downing Ventures invests in
Countries Downing Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $550k–$4.7M
- Series A
- $3.2M–$13M
Investment Focus
Industry
- Software 23 (18%)
- Health Care 17 (13%)
- Information Technology 13 (10%)
- Artificial Intelligence 12 (9%)
- Biotechnology 10 (8%)
Stage
- Funding Round 31 (24%)
- Series A 29 (22%)
- Seed 28 (21%)
- Series B 9 (7%)
- Venture - Series Unknown 4 (3%)
Country
- United Kingdom 71 (54%)
- United States 7 (5%)
- Israel 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kostas Manolis
Partner and Head of Unquoted Investments
|
Partner and Head of Unquoted Investments | Total investments: 2 | Find email | |
Mike Kennedy
Ventures Adviser - Downing Ventures
|
Ventures Adviser - Downing Ventures | Total investments: 3 | Find email | |
Nick Lewis
Founding Partner, Investment Committee Member & Chairman
|
Founding Partner, Investment Committee Member & Chairman | Total investments: 0 | Find email | |
Sophie Andre
Portfolio and Operations Manager
|
Portfolio and Operations Manager | Total investments: 0 | Find email | |
Chris Allner
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 12 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TidalSense
|
CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath. | $3.2M / Seed / May 16, 2023 | |
Qkine
|
Qkine manufactures high-purity, animal-free growth factors, cytokines and other complex proteins. Based on the Cambridge Science Park, UK, we combine proprietary protein production processes developed at the University of Cambridge with protein engineering techniques to develop unique products that tackle fundamental biological and scale-upchallenges for the fast-growing stem cell, organoid, regenerative medicine and cultivated meat sectors. Qkine has an active R&D pipeline, with a continually expanding product range. Unique products available from Qkine include tag-free thermostable FGF-2 (FGF2-G3), the first animal-free TGF beta 1 for chemically defined stem cell media, and animal-free HGF (NK1). Qkine is an ISO 9001: 2015 certified company. | $5.2M / Series B / Dec 15, 2022 | |
FundamentalVR
|
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals. | $20M / Series B / Aug 11, 2022 | |
BBC Maestro
|
BBC Maestro is a streaming platform that was developed to teach and inspire individuals to explore their creativity. Anyone can master a wide range of disciplines and follow in the footsteps of specialists respected all over the world by using pre-recorded classes and complete course notes. | Seed / Aug 01, 2022 | |
Distributed
|
Distributed is a software development company that develops an on-demand Elastic Team that allows getting things done faster. Through the Distributed platform, clients can work with fully managed, globally distributed teams of highly skilled software engineers allowing them to build and maintain software faster, more efficiently, cost-effectively,and with more visibility than ever before. The company was founded in 2017 and is based in London, England. | $10.5M / Jun 30, 2022 | |
|
Distributed
|
Distributed is a software development company that develops an on-demand Elastic Team that allows getting things done faster. Through the Distributed platform, clients can work with fully managed, globally distributed teams of highly skilled software engineers allowing them to build and maintain software faster, more efficiently, cost-effectively,and with more visibility than ever before. The company was founded in 2017 and is based in London, England. | $9.7M / Series A / Jun 29, 2022 | |
Glisser
|
Glisser is an award-winning tech platform powering unique company event experiences, anywhere. Our best-in-class virtual and hybrid event tools give planners the power to wow and make every event count. Clients include KPMG, Pfizer, Informa, Facebook, Uber, and many more.The platform is developed by event industry veterans to go beyond basicvideo and screen sharing tech, to create inspiring, high participation events of any size, whether it’s a highly focused interactive training session or communicating to 150,000 attendees across the globe. | Venture - Series Unknown / May 17, 2022 | |
Dragonfly AI
|
Dragonfly AI is a predictive heatmap that shows exactly what catches the audience's attention first across any content, allow us to make data-informed decisions without holding business down. Get real-time insight into what genuinely catches their customers' attention. Predictive analytics can help us increase efficiency throughout thedesign cycle. Improve the success rate across all channels. Increase their ROI by increasing their share of attention across channels. | $3.9M / Series A / Apr 11, 2022 | |
Virtuoso
|
Virtuoso uses artificial intelligence, machine learning, and robotic process automation to run a test automation tool that gives the speed of codeless paired with the power of scripted test steps. They develop codeless test automation software without slowing down the development process. They provide functional UI testing and continuous testingsolutions. | $13.3M / Series A / Nov 15, 2021 | |
Closed Loop Medicine
|
Closed Loop Medicine is the global leader in the development of single prescription drug plus digital therapy (DTx) combination products developed to optimise dosing on an individual level with linked behaviour therapy to improve patient outcomes. The company was founded by an experienced team of healthcare professionals, entrepreneurs and lifescientists with experience of both drug and software development, as well as extensive health system innovation experience. The company has two products in development for hypertension and insomnia. It has further products in its pipeline for a wide portfolio of chronic diseases. The Company ensures that both patient and clinician are at the centre of its products design and development. | $16.6M / Series A / Nov 03, 2021 | |
| See all 131 investments → | |||
Co-Investors
London Co-Investment Fund
16 deals together
Business Growth Fund
10 deals together
Forward Partners
6 deals together
Capita
5 deals together
Amadeus Capital Partners
4 deals together
Guinness Ventures
4 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Downing Ventures invest in?
Downing Ventures invests primarily in Software, Health Care and Information Technology startups, most often at Funding Round and Series A stage. Most of the 131 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Downing Ventures's check size?
Downing Ventures typically joins rounds of $550k–$4.7M at Seed and $3.2M–$13M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Downing Ventures participates in.
How do I contact Downing Ventures?
Public channels for Downing Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Downing Ventures?
The team at Downing Ventures includes Kostas Manolis (Partner and Head of Unquoted Investments), Mike Kennedy (Ventures Adviser - Downing Ventures) and Nick Lewis (Founding Partner, Investment Committee Member & Chairman), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
